Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Xi Yang"'
Autor:
Dongming Zhou, Jing Pan, Chuo Li, Erlie Jiang, Xiaolei Sun, Sheng Wang, Xi Yang, Xiaoming Feng, Shiyu Zuo, Qing Niu, Huifang Huang, Haidong Cui, Guoling Wang, Min Liu, Zihao Fang, Qi Deng, Yonghui Xia, Yanyu Jiang, Yuan Meng
Publikováno v:
Journal of Hematology & Oncology
Journal of Hematology & Oncology, Vol 14, Iss 1, Pp 1-6 (2021)
Journal of Hematology & Oncology, Vol 14, Iss 1, Pp 1-6 (2021)
CD19 chimeric antigen receptor (CAR)-T cells have been used to treat patients with refractory chronic lymphocytic leukemia (CLL). However, approximately 50% of patients do not respond to this therapy. To improve the clinical outcome of these patients
Publikováno v:
Molecular Cancer
Molecular Cancer, Vol 20, Iss 1, Pp 1-17 (2021)
Molecular Cancer, Vol 20, Iss 1, Pp 1-17 (2021)
Circulating tumor cells are tumor cells with high vitality and high metastatic potential that invade and shed into the peripheral blood from primary solid tumors or metastatic foci. Due to the heterogeneity of tumors, it is difficult for high-through
Publikováno v:
BMC Cancer
BMC Cancer, Vol 20, Iss 1, Pp 1-14 (2020)
BMC Cancer, Vol 20, Iss 1, Pp 1-14 (2020)
Background Previous researches have reported that tripartite motif-containing 44 (TRIM44) is related to the prognosis of multiple human tumors. This study was designed to systematically assess the prognostic value of TRIM44 in human malignancies and
Autor:
Jiang Li, Chenping Zhang, Yong-jie Hu, Lai-ping Zhong, Guo-xin Ren, Wen-jun Yang, Xi Yang, Guo-yu Zhou, Wei Guo
Publikováno v:
BMC Cancer
BMC Cancer, Vol 10, Iss 1, p 623 (2010)
BMC Cancer, Vol 10, Iss 1, p 623 (2010)
Background Oral mucosal melanoma (OMM) is a clinically rare disease with poor prognosis. Various treatment methods have been investigated with the aim of improving the prognosis. This study aimed to analyze the data of a single institution in the man